ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Proton Beam Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis

https://repo.qst.go.jp/records/45811
https://repo.qst.go.jp/records/45811
586184f9-f022-422e-bb23-78eba613cc69
Item type 学術雑誌論文 / Journal Article(1)
公開日 2010-06-16
タイトル
タイトル Proton Beam Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Sugahara, Shinji

× Sugahara, Shinji

WEKO 455513

Sugahara, Shinji

Search repository
Nakayama, Hidetsugu

× Nakayama, Hidetsugu

WEKO 455514

Nakayama, Hidetsugu

Search repository
Tsuboi, Koji

× Tsuboi, Koji

WEKO 455515

Tsuboi, Koji

Search repository
Tokuue, Kouichi

× Tokuue, Kouichi

WEKO 455516

Tokuue, Kouichi

Search repository
et.al

× et.al

WEKO 455517

et.al

Search repository
菅原 信二

× 菅原 信二

WEKO 455518

en 菅原 信二

Search repository
中山 秀次

× 中山 秀次

WEKO 455519

en 中山 秀次

Search repository
坪井 康次

× 坪井 康次

WEKO 455520

en 坪井 康次

Search repository
抄録
内容記述タイプ Abstract
内容記述 Background and Purpose: The prognosis of patients with advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is extremely poor, as effective treatment options are limited. The authors performed a retrospective review to evaluate the efficacy of proton-beam therapy (PBT) for patients presenting with PVTT in the setting of HCC.
Patients and Methods: Between February 1991 and September 2005, 35 patients with HCC and tumor thrombi in the main trunk or major branches of the portal vein presented for consideration of PBT. Their tumor sizes ranged from 25 mm to 130 mm (median, 60 mm). A median total dose of 72.6 GyE in 22 fractions was delivered over 31 days to a target volume that encompassed both the primary hepatic lesion and the PVTT.
Results: 32 patients were progression-free during a median follow-up period of 21 months (range, 2-88 months) and three patients experienced disease progression. Local progression-free survival rates were 46% at 2 years and 20% at 5 years, and the median local progression-free survival was 21month. Acute toxicity ≥ grade 3 was observed in three patients, and no patient experienced late toxicity ≥ grade 3. None of the patients had to discontinue treatment as a result of toxicity.
Conclusion: PBT improved local control and significantly prolonged survival in HCC patients with PVTT.
書誌情報 Strahlentherapie und Onkologie

巻 185, 号 12, p. 782-788, 発行日 2009-12
ISSN
収録物識別子タイプ ISSN
収録物識別子 0179-7158
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:59:19.382025
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3